Related Experiment Video
Updated: Jan 1, 2026
10:11
Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research
Published on: October 27, 2023
1.4K
Review: mesenchymal stem cells and corneal reconstruction
1Qingdao Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao, China.
Molecular Vision
|November 15, 2013
Summary
Mesenchymal stem cells (MSCs) show promise for corneal reconstruction due to their self-renewal and differentiation capabilities. Their anti-inflammatory and immunomodulatory effects are key to treating corneal injuries.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Corneal reconstruction is vital for treating vision impairment from various disorders.
- Mesenchymal stem cells (MSCs) are multipotent cells easily isolated and expanded in vitro.
- MSCs possess self-renewal and transdifferentiation potential.
Purpose of the Study:
- To review the current understanding of Mesenchymal stem cells (MSCs) roles in corneal reconstruction.
- To highlight the therapeutic potential of MSCs for corneal repair.
Main Methods:
- Literature review of studies on Mesenchymal stem cells (MSCs) in corneal applications.
- Summary of in vitro and in vivo findings regarding MSC properties relevant to the cornea.
Main Results:
- Mesenchymal stem cells (MSCs) exhibit self-renewal and can differentiate into corneal cell types.
- Confirmed immunomodulatory, anti-inflammatory, and angiogenesis-modulating properties of MSCs in animal models.
- These properties are crucial for successful corneal reconstruction.
Conclusions:
- Mesenchymal stem cells (MSCs) offer significant potential for corneal reconstruction.
- Further research into MSC-based therapies could revolutionize the treatment of corneal diseases.
